Why this CAR T advance matters: Complete remissions without chemotherapy at doses as low as 250,000 cells/kg

Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...
Clinical Advisor

Saphnelo SC Approval Expands Delivery Options for SLE Patients

The new weekly 120 mg SC formulation, supported by TULIP-SC trial results, offers patients with moderate to severe SLE a self-administered alternative to monthly IV infusions.
Medscape

EMA Broadens Use of Targeted Combinations in Blood Cancers

The EMA has recommended label expansions for Inaqovi, Opdivo, and Venclyxto, broadening treatment options in AML, Hodgkin lymphoma, and CLL.
Frontiers

Advanced Human Cell Platforms for Infectious Disease Drug Discovery toward Clinical Translation

The field of infectious disease research faces persistent challenges in bridging the gap between laboratory findings and successful clinical translation.